Reversible binding of the anticancer drug KXO1 (tirbanibulin) to the colchicine-binding site of β-tubulin explains KXO1’s low clinical toxicity
Reversible binding of the anticancer drug KXO1 (tirbanibulin) to the colchicine-binding site of β-tubulin explains KXO1’s low clinical toxicity
复制标题
抗癌药物 KXO1（tirbanibulin）与 β-微管蛋白的秋水仙碱结合位点的可逆结合解释了 KXO1 的低临床毒性
作者：
牛璐;杨建洪;闫伟;余亚梅;郑云华;叶昊宇;陈强;陈俐娟
